Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

97results about How to "Significant utility" patented technology

Apparatus for the purification of water and method therefor

An apparatus and method for the purification of contaminated water whereby the contamination level of the wastewater is automatically monitored and treatment self-adjusted and continued until the desired level of purification is reached. Specifically, if upon treatment a pre-set purification level is not obtained a water recycle control means completely precludes the uptake of additional contaminated water and recycles wastewater within the apparatus until the desired level of purification is obtained. The present invention more particularly pertains to an efficient, turn key, economical, movable, automatic and compact apparatus and method for treating a fluid with ozone comprising multiple pressurized contact columns which are arranged in a hybrid parallel and series column configuration, which utilizes a unique water recycle control system and piping arrangement to improve the efficiency of the mass transfer of ozone into the water and increase its solubility by increasing the contact time between the water phase and the gas phase. The apparatus and method of the present invention has the further advantage that it requires minimal installation and may be used to fulfill the clean and safe water needs of any hotel, resort, restaurant, hospital, light industry, commercial business, apartment complex or small city.
Owner:AGRIMOND USA CORP

Multiple-use cover with see through carrying article

InactiveUS20050133558A1Easily screenSecurity and privacyPursesLuggageCheck pointEngineering
A multiple-use cover with an easy access opening used to cover a see through carrying article such as a backpack, tote bag or diaper bag. The easy access opening on multiple-use cover allows user to gain access to the inside of the carrying article and its pockets through an opening in the multiple-use cover. The easy access opening consists of a zipper or flap opening on multiple-use cover used to gain access to see through carrying article without having to remove the cover. The multiple-use cover is useful when the user is carrying a see through carrying article such as backpack or tote bag and wants to protect the privacy of what they are carrying thus enhancing their own personal safety during their commute. The cover allows a user to spend less time getting through check points in a secure environment by allowing the user to remove the cover for quick examination of the see through carrying article. The multiple-use cover pocket(s) can be made see through with a see through lining which would allow a screener to quickly examine them. The shape of the multiple-use cover can be made to fit any type of see through carrying article with or without wheels and provides great utility in that it allows the user to utilize the shoulder strap(s) and handgrip found on most carrying articles such as backpacks or tote bags. The multiple-use cover can be made to be worn on either side or inside out. When the cover is no longer needed it can be converted into a pouch and stored away inside carrying article or worn as a fanny pack or bag around waist or shoulder.
Owner:TOOMBS TIMOTHY BERNARD

Methods for identifying drug pharmacology and toxicology

The invention combines a microarray and cell-based screening strategy that enables rapid identification of possible mechanisms underpinning the pharmacology and toxicology of drug candidates. The methods of the invention identified unique properties relating to apoptosis and the anti-inflammatory response elicited by several peroxisome proliferator activated receptor gamma (PPARγ) ligands. The methods illustrate, for example, that PPARγ ligands that are safe and effective drugs (e.g., Actos, Avandia) either do not induce apoptosis or only modestly induce apoptosis. Conversely, PPARγ ligands that have failed clinical development (e.g., Ciglitazone; Day, C., Diabet. Med., 16: 179-192 (1999)) or that have been withdrawn from the market (e.g., Troglitazone (Rezulin)) due to hepatotoxicity are potent inducers of apoptosis. The methods of the invention also illustrate that suppression of gene expression and protein expression for several pro-inflammatory factors by some PPARγ ligands occurs as a consequence of apoptotic induction (i.e., apoptosis produces an anti-inflammatory response). The invention also provides biomarkers for cellular pathways and methods for stratifying patient groups according to their biomarker expression as well as biomarkers that discriminate safe and effective drugs from compounds that have acute toxicities. These biomarkers provide novel insights into the mechanism of action and toxicity for test compounds, including cell death, anti-inflammatory activity, hepatotoxicity, and carcinogenicity. The methods are highly scalable and have broad application from discovery to the clinic, including compound prioritization, predictive pharmacology and toxicology; mechanism of action studies; and prognostic and diagnostic biomarker discovery.
Owner:RIBONOMICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products